Axa S.A. Lantheus Holdings, Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Axa S.A. holds 12,614 shares of LNTH stock, worth $679,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,614

Previous 11,824 6.68%

Holding current value

$679,011

Previous $1.15 Million 10.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$73.86 - $108.74 $58,349 - $85,904	790 Added 6.68%	12,614 $1.03 Million
Q1 2025 May 15, 2025	BUY	$78.23 - $110.01 $278,811 - $392,075	3,564 Added 43.15%	11,824 $1.15 Million
Q4 2024 Feb 14, 2025	SELL	$76.22 - $116.71 $4.77 Million - $7.3 Million	-62,518 Reduced 88.33%	8,260 $738,000
Q3 2024 Nov 14, 2024	SELL	$77.7 - $123.62 $1.44 Million - $2.29 Million	-18,493 Reduced 20.72%	70,778 $7.77 Million
Q2 2024 Feb 25, 2025	BUY	$58.87 - $83.05 $4.77 Million - $6.73 Million	81,011 Added 980.76%	89,271 $7.17 Million
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $349,864 - $493,566	5,943 Added 7.13%	89,271 $7.17 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $3.25 Million - $4.35 Million	63,728 Added 325.14%	83,328 $5.19 Million
Q4 2023 Jul 16, 2024	SELL	$55.6 - $77.89 $3.54 Million - $4.96 Million	-63,728 Reduced 76.48%	19,600 $1.22 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $161,240 - $225,881	-2,900 Reduced 12.89%	19,600 $1.22 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $48,216 - $72,600	-800 Reduced 3.43%	22,500 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $1.92 Million - $2.32 Million	23,300 New	23,300 $1.96 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $492,476 - $784,467	-10,100 Closed	0 $0
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $620,342 - $871,529	10,100 New	10,100 $711,000
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $453,054 - $611,844	-20,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.23 - $28.59 $16,961 - $20,013	-700 Reduced 3.37%	20,100 $516,000
Q1 2021 May 14, 2021	SELL	$13.77 - $21.66 $2.31 Million - $3.64 Million	-168,100 Reduced 88.99%	20,800 $444,000
Q2 2020 Aug 14, 2020	BUY	$10.34 - $15.51 $803,418 - $1.21 Million	77,700 Added 69.87%	188,900 $2.7 Million
Q1 2020 May 15, 2020	SELL	$9.11 - $20.05 $307,918 - $677,690	-33,800 Reduced 23.31%	111,200 $1.42 Million
Q4 2019 Feb 18, 2020	BUY	$18.47 - $24.03 $511,618 - $665,631	27,700 Added 23.61%	145,000 $2.97 Million
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $506,341 - $697,454	-24,100 Reduced 17.04%	117,300 $2.94 Million
Q2 2019 Aug 13, 2019	BUY	$23.33 - $28.3 $2.37 Million - $2.87 Million	101,500 Added 254.39%	141,400 $4 Million
Q1 2019 May 14, 2019	BUY	$14.93 - $25.1 $595,707 - $1 Million	39,900 New	39,900 $977,000

Others Institutions Holding LNTH

# of Institutions

542

Shares Held

77.9M

Call Options Held

710K

Put Options Held

433K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account